In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 1 Expert Committee has revised the Valacyclovir Tablets monograph. The purpose of this revision is to add Dissolution Test 2 for a generic product approved by the FDA. Minor corrections were made to clarify the terms in the formula for Dissolution Test 1 and Procedure for Content Uniformity.
The Valacyclovir Tablets Revision Bulletin supersedes the currently official monograph and will be incorporated in the USP 36–NF 31.
Should you have any questions, please contact Leonel Santos (301-816-8168 or email@example.com).